The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB

Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis

(2014) Michael Buszczak et al.   CELL

IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma

(2014) Yuanyuan Gao et al.   HUMAN PATHOLOGY

Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity

(2014) M. B. Fuertes et al.   JOURNAL OF IMMUNOLOGY

Post-transcriptional coordination of immunological responses by RNA-binding proteins

(2014) Panagiota Kafasla et al.   NATURE IMMUNOLOGY

A census of human RNA-binding proteins

(2014) Stefanie Gerstberger et al.   NATURE REVIEWS GENETICS

Role of IGF2BP3 in trophoblast cell invasion and migration

(2014) W Li et al.   Cell Death & Disease

RNA-binding proteins regulate the expression of the immune activating ligand MICB

(2014) Daphna Nachmani et al.   Nature Communications

Regulation of Ligands for the NKG2D Activating Receptor

(2013) David H. Raulet et al.   Annual Review of Immunology

Natural Killer Cells and Antifungal Host Response

(2013) Stanislaw Schmidt et al.   Clinical and Vaccine Immunology

Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)

(2013) Monika Hämmerle et al.   HEPATOLOGY

IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma

(2013) Hongping Tang et al.   HUMAN PATHOLOGY

Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma

(2013) Kai Chen et al.   HUMAN PATHOLOGY

At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies

(2013) Franco Locatelli et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma

(2013) Ming Zhou et al.   JOURNAL OF NEURO-ONCOLOGY

Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the Bladder

(2013) Evanguelos Xylinas et al.   JOURNAL OF UROLOGY

Natural killer cells: walking three paths down memory lane

(2013) Gundula Min-Oo et al.   TRENDS IN IMMUNOLOGY

Activating natural cytotoxicity receptors of natural killer cells in cancer and infection

(2013) Joachim Koch et al.   TRENDS IN IMMUNOLOGY

Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma

(2013) LIJUAN LIN et al.   Oncology Letters

Virus-mediated inhibition of natural cytotoxicity receptor recognition

(2012) Einat Seidel et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

(2012) Paul Lochhead et al.   EUROPEAN JOURNAL OF CANCER

Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression

(2012) Elena M Hartmann et al.   MODERN PATHOLOGY

Battle of the midgets

(2012) Shlomo Elias et al.   RNA Biology

An Identical miRNA of the Human JC and BK Polyoma Viruses Targets the Stress-Induced Ligand ULBP3 to Escape Immune Elimination

(2011) Yoav Bauman et al.   Cell Host & Microbe

NK Cells and Immune "Memory"

(2011) J. C. Sun et al.   JOURNAL OF IMMUNOLOGY

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

Persistence of decidual NK cells and KIR genotypes in healthy pregnant and preeclamptic women: a case-control study in the third trimester of gestation

(2011) Elly N Sánchez-Rodríguez et al.   Reproductive Biology and Endocrinology

MicroRNA based immunoevasion mechanism of human polyomaviruses

(2011) Yoav Bauman et al.   RNA Biology

Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP

(2010) Markus Hafner et al.   CELL

IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA

(2010) Stephan Kloess et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands

(2010) Lola Fernández-Messina et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination

(2010) Daphna Nachmani et al.   NATURE IMMUNOLOGY

An Oncofetal Protein IMP3

(2009) Di Lu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

(2009) Dawei Li et al.   ANNALS OF SURGICAL ONCOLOGY

Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells

(2009) Daphna Nachmani et al.   Cell Host & Microbe

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

(2009) Otto Walter et al.   HUMAN PATHOLOGY

IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue

(2009) Rebecca L. King et al.   HUMAN PATHOLOGY

IMP3 expression in non–small cell lung cancer

(2009) Guido Bellezza et al.   HUMAN PATHOLOGY

An integrated view of the regulation of NKG2D ligands

(2009) Noam Stern-Ginossar et al.   IMMUNOLOGY

Analysis of Human Cytomegalovirus-Encoded MicroRNA Activity during Infection

(2009) N. Stern-Ginossar et al.   JOURNAL OF VIROLOGY

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

(2009) Martin Köbel et al.   MODERN PATHOLOGY

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

(2008) Nathan E. Hoffmann et al.   CANCER

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

(2008) L. Sitnikova et al.   CLINICAL CANCER RESEARCH

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

(2008) Z. Jiang et al.   CLINICAL CANCER RESEARCH